Company Directory > CDMO > Itaan Pharma
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Itaan Pharma and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Itaan Pharma is a science-based pharmaceutical company specializing in the development and manufacturing of specialty injectable formulations. The company focuses on niche, patient-critical sterile products, leveraging expertise in formulation development, process development, and commercial-scale manufacturing to serve regulated markets including the U.S., Canada, and India. Operating as a CDMO and developer, Itaan Pharma maintains state-of-the-art R&D and manufacturing facilities, including a site in Genome Valley, India, and offices in the United States and Canada. The company emphasizes compliance with global regulatory standards (FDA, Health Canada, EMA) and utilizes advanced technologies such as aseptic filling for glass and polypropylene vials.
CLASSIFICATION
Company Type:CDMO
Therapeutic Areas:-
Industry:Pharmaceuticals
Sub-Industry:Injectables / CDMO
SIZE & FINANCIALS
Employees:51-200
Founded:2020
Ownership:private
Status:operating
PIPELINE
Stage:Development
Lead Drug Stage:ANDA/ANDS development
Modalities:Small molecule, Sterile injectables
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Itaan Pharma Inc. (USA), Itaan Pharma Canada Inc.
Key Partnerships:ACIC Pharmaceuticals (Strategic joint venture for injectable products)
COMPETITION
Position:Emerging
Competitors:Austin Company
LEADERSHIP
Key Executives:
Dr. Ajay Pazhayattil - Partner-Director
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Itaan Pharma. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.